Cargando…

Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model

INTRODUCTION: Chronic headache conditions are characterized by persistent sensitization of the trigeminal system, which involves dysfunction of descending pain modulation. We previously reported that noninvasive vagus nerve stimulation (nVNS) inhibits trigeminal nociception in models of episodic mig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornelison, Lauren E., Hawkins, Jordan L., Woodman, Sara E., Durham, Paul L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Headache and Orofacial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752694/ https://www.ncbi.nlm.nih.gov/pubmed/33364541 http://dx.doi.org/10.1097/PR9.0000000000000881

Ejemplares similares

Trigeminal neuropathy presenting secondary to SARS-CoV-2 infection
por: O'Neill, Francis, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 infection altered the factors associated with headache: evidence from a multicenter community-based case–control study
por: Ali, Mohammad
Publicado: (2022)

Multivariate classification of pain-evoked brain activity in temporomandibular disorder
por: Harper, Daniel E., et al.
Publicado: (2016)

Optimizing resilience in orofacial pain: a randomized controlled pilot study on hope
por: Bartley, Emily J., et al.
Publicado: (2019)

Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study
por: Grosberg, Brian, et al.
Publicado: (2021)

Orofacial pain in 1916 patients with early or moderate Parkinson disease
por: O'Neill, Francis, et al.
Publicado: (2021)

Preliminary evidence for conserved transcriptional response to adversity in adults with temporomandibular disorder
por: King, Christopher D., et al.
Publicado: (2021)

Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine
por: Hawkins, Jordan L., et al.
Publicado: (2017)

Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine
por: Cornelison, Lauren E., et al.
Publicado: (2020)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Headache advocacy
por: Grisold, Wolfgang, et al.
Publicado: (2023)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

When cluster headache was called histaminic cephalalgia (Horton’s headache)
por: Fanciullacci, M.
Publicado: (2006)

Dolor orofacial según Bell
por: Okeson, Jeffrey P.
Publicado: (1999)

Dolor odonto estomatológico /
Publicado: (2007)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Chronic daily headache in a paediatric headache centre
por: Scalas, C., et al.
Publicado: (2005)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Attachment styles and headache
por: Savi, L., et al.
Publicado: (2005)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Vagus nerve stimulation: Invasive or noninvasive?
por: Anfinogenova, Yana
Publicado: (2016)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_7c0fcr921s00ee1eaa81gqvg2l